Business Context and Reporting Period
This Form 8-K is a current report filed by India Globalization Capital, Inc. (referred to in the request as IGC Pharma, Inc.) on February 28, 2018. The filing addresses a corporate governance event regarding the adjournment of shareholder voting for a specific proposal from the Annual Meeting of Shareholders originally scheduled in October 2017.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a procedural corporate event and contains no financial performance data.
Material Changes
The material change reported is the adjournment of the voting for Proposal Four. This proposal seeks shareholder approval for the issuance of up to 2,000,000 shares of the Company's common stock to Bricoleur Partners, L.P. The voting deadline has been extended to April 30, 2018, to allow stockholders additional time to cast their votes.
Guidance, Outlook, and Management Commentary
Management has stated that proxies previously submitted will be voted at the adjourned meeting unless properly revoked. The Company will continue to solicit proxies specifically for Proposal Four during the adjournment period. No financial guidance, risk factors, or contingencies are disclosed in this specific filing.
Key Facts for Investor Verification
- The voting for the issuance of 2,000,000 shares to Bricoleur Partners, L.P. has been adjourned to April 30, 2018.
- Stockholders who have already voted do not need to recast their votes.
- The Company is actively soliciting additional proxies for this specific proposal.
- The registrant's legal name is India Globalization Capital, Inc., not IGC Pharma, Inc.